30 November – 3 December 2021
On demand presentation, available to watch from the 22nd November. Issues with Health Technology Assessment of Specialised Technologies (16.30 -16.45). Rita Faria presents ' Better outcomes and value for money with cost-effectiveness modelling of cascade screening strategies for familial hypercholesterolaemia.
Tuesday 30 November
Defining established clinical management in the era of managed access in HTA
Mark Sculpher will be a panelist on this session.
Issue panels and workshops 12.30 -13.30
What are the benefits of treatment of familial hypercholesterolaemia? A cost-effectiveness model based on real-world data considering cholesterol burden
Poster presentation by Rita Faria
Virtual poster discussion session 1 13.30 - 16.00
Wednesday 1 December
Methods to estimate the value of new antibiotics in the context of antimicrobial resistance
Spotlight session 16.00 - 17.00
Health equity in HEOR: The state of play
Session speaker Richard Cookson
ISPOR Forums 16:00 - 17:00
Thursday 2 December
Cost effectiveness analysis of diagnostic and screening strategies: When and how to compare a googolplex of strategies?
Discussant Rita Faria
Issue Panels and workshops - Live workshop 12.30-13.30
Friday 3 December
See the future: How important will structured expert elicitation become for HTA in the next 5 years?
Discussant Laura Bojke
Issue Panels and workshops - Live workshop 11.30-12.00